How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Gastrointestinal Catheter Market
- By Product Type: Nasogastric Catheters, Nasojejunal Catheters, Gastrostomy Catheters, Jejunostomy Catheters, Rectal Catheters
- By Material: Silicone, Polyurethane, Latex, PVC (Polyvinyl Chloride)
- By Application: Enteral Feeding, Decompression, Drainage, Medication Administration
- By End User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics
- By Catheter Design: Single Lumen, Double Lumen, Balloon Catheters, Weighted Tip Catheters
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Nasogastric Catheters leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Gastrointestinal Catheter Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Material 4
Application 4
End User 4
Catheter Design 4
Companies profiled
Medtronic
Boston Scientific Corporation
Cook Medical
Becton Dickinson and Company (BD)
Teleflex Incorporated
C.R. Bard (now part of BD)
ConvaTec Group PLC
Halyard Health (now part of Owens & Minor)
Fresenius SE & Co. KGaA
Smiths Medical
Nipro Corporation
B. Braun Melsungen AG
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Cook Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Teleflex Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →C.R. Bard (now part of BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →ConvaTec Group PLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Halyard Health (now part of Owens & Minor)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Fresenius SE & Co. KGaA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Smiths Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Sewoon Medical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Olympus Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →AngioDynamics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,600M by 2033 · 9.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Nasogastric Catheters48.3
- Nasojejunal Catheters16.0
- Gastrostomy Catheters11.0
- Jejunostomy Catheters9.2
- Rectal Catheters15.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$414.7M → $892.1M · 10.0%
Europe$289.1M → $623.5M · 10.1%
Asia Pacific$263.9M → $497.3M · 8.2%
Latin America$163.4M → $329.3M · 9.2%
Middle East and Africa$125.7M → $253.0M · 9.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.472026
9.472027
9.482028
9.502029
9.522030
9.532031
9.532032
9.542033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic14.8
- Boston Scientific Corporation21.8
- Cook Medical9.3
- Becton Dickinson and Company (BD)6.6
- Teleflex Incorporated11.6
- C.R. Bard (now part of BD)7.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type26.6%
Material23.1%
Application14.0%
End User13.1%
Catheter Design23.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.4
- Europe24.0
- Asia Pacific19.2
- Latin America12.7
- Middle East and Africa9.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 84 | 93 | 73 | 82 | 90 | 77 | 83 |
| Boston Scientific Corporation | 80 | 80 | 74 | 85 | 84 | 79 | 80 |
| Cook Medical | 75 | 69 | 78 | 62 | 73 | 83 | 73 |
| Becton Dickinson and Company (BD) | 60 | 73 | 76 | 81 | 69 | 60 | 70 |
| Teleflex Incorporated | 58 | 57 | 58 | 69 | 70 | 58 | 62 |
| C.R. Bard (now part of BD) | 47 | 61 | 49 | 51 | 46 | 55 | 52 |
| ConvaTec Group PLC | 49 | 50 | 60 | 63 | 64 | 60 | 58 |
| Halyard Health (now part of Owens & Minor) | 35 | 55 | 43 | 58 | 41 | 39 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- Boston Scientific Corporation
- Cook Medical
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Boston Scientific Corporation | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Cook Medical | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Becton Dickinson and Company (BD) | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Teleflex Incorporated | − | − | − | ◐ | − | ◐ |
| C.R. Bard (now part of BD) | ◐ | ◐ | − | − | − | ◐ |
| ConvaTec Group PLC | ◐ | − | ◐ | − | − | ◐ |
| Halyard Health (now part of Owens & Minor) | − | ◐ | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic83
2Boston Scientific Corporation80
3Cook Medical73
4Becton Dickinson and Company (BD)70
5Teleflex Incorporated62
6ConvaTec Group PLC58
7C.R. Bard (now part of BD)52
8Halyard Health (now part of Owens & Minor)45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
MedtronicBoston Scientific Corporation
Challenger2
Strong scale, closing on the leaders.
Cook MedicalBecton Dickinson and Company (BD)
Contender2
Focused players with pockets of strength.
Teleflex IncorporatedConvaTec Group PLC
Niche2
Specialists in a single segment or region.
C.R. Bard (now part of BD)Halyard Health (now part of Owens & Minor)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Gastrointestinal Catheter Market — a $515M beachhead inside a $7.77B market.
Beachhead (SOM)$515Mobtainable near-term
Serviceable (SAM)$2.79Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Nasogastric Catheters
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Nasojejunal Catheters
Strong fit — clear ROI and a fast path to value.
End user64 fit
Gastrostomy Catheters
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel30%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Gastrointestinal Catheter Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified25%
Evaluation15%
Closed-won6%
$21.5KCAC
$93KLTV
4.3:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Gastrointestinal Catheter Market is a resilient opportunity — $6.67B by 2033, compounding at 5.2%.
TAM · 2025$4.44Btoday
TAM · 2033$6.67Bforecast
CAGR5.2%2027–2033
Cumulative$49.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.67BTotal addressable market
SAM$2.45BServiceable available market
SOM$421MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.2% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.67BLarge & growingTAM by 2033 at 5.2% CAGR
$2.45BServiceable nowreachable with today’s model
$421MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.21BBear3.4% CAGR
$6.67BBase5.2% CAGR
$8.54BBull6.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Gastrointestinal Catheter Market — a $11.3B market by 2033. Plan: grow share from 8.3% to 15.7%.
Market size · 2033$11.3Btotal addressable
Market CAGR10.1%2027–2033
Target share15.7%from 8.3% today
Revenue ambition$1.77Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.3% | 15.7% | At risk |
| Revenue | $873M | $1.77B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 28.1% | 41.0% | On track |
| Customer retention | 87.7% | 92.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material capability
A defensible second engine — invest in Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $262M capacity & capability investment
- Greenlight bolt-on M&A in Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Gastrointestinal Catheter Market conversation — a $4.63B market you can size, segment and defend in minutes.
Market size · 2033$4.63Btotal opportunity
Growth10.0%CAGR to 2033
Addressable buyers1,699+accounts in scope
Typical ROI5.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.4×return on cost, year one
< 2 mopayback period
$87K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
MedtronicBoston Scientific CorporationCook MedicalBecton Dickinson and Company (BD)Teleflex IncorporatedC.R. Bard (now part of BD)ConvaTec Group PLCHalyard Health (now part of Owens & Minor)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Gastrointestinal Catheter Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Gastrointestinal Catheter Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Gastrointestinal Capsule Endoscopy Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportGastrointestinal Biodegradable Stents Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportGastrointestinal Bacterial Testing Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportGastroesophageal Reflux Therapeutic Instrument Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportGastroesophageal Reflux Drugs Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportGastroesophageal Reflux Disease (GERD) Treatment Devices Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportGastroesophageal Reflux Disease (GERD) Drugs and Devices Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportGastroesophageal Reflux Disease (GERD) Diagnosis Products Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportGastroesophageal Reflux Disease Device Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportGastroesophageal Junction Adenocarcinoma Therapeutics Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportIndustrial Imager Market
Market size, share, segmentation and regional forecast.
$864M market · 2025 base year
View reportGastroesophageal Impedance PH Meter Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.